HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 11564811)

Published in J Immunol on October 01, 2001

Authors

K R Jerome1, Z Chen, R Lang, M R Torres, J Hofmeister, S Smith, R Fox, C J Froelich, L Corey

Author Affiliations

1: Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. kjerome@fhcrc.org

Articles citing this

Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci U S A (2004) 1.72

Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev (2003) 1.62

Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J Virol (2006) 1.54

Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J Virol (2005) 1.45

Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1. J Virol (2006) 1.21

Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J Virol (2008) 1.16

Infection of cattle with a bovine herpesvirus 1 strain that contains a mutation in the latency-related gene leads to increased apoptosis in trigeminal ganglia during the transition from acute infection to latency. J Virol (2003) 1.14

The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol (2003) 1.13

The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J Virol (2010) 1.12

Cells lacking NF-kappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus. J Virol (2004) 1.09

Immunological control of herpes simplex virus infections. J Neurovirol (2013) 1.08

Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis (2010) 1.05

HSV Recombinant Vectors for Gene Therapy. Open Virol J (2010) 0.99

Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J Virol (2007) 0.99

Sequence and genetic arrangement of the U(S) region of the monkey B virus (cercopithecine herpesvirus 1) genome and comparison with the U(S) regions of other primate herpesviruses. J Virol (2002) 0.96

Activation and evasion of innate antiviral immunity by herpes simplex virus. Viruses (2009) 0.94

Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus. Virology (2006) 0.93

US3 protein kinase of HSV-1 cycles between the cytoplasm and nucleus and interacts with programmed cell death protein 4 (PDCD4) to block apoptosis. Proc Natl Acad Sci U S A (2011) 0.92

Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress. PLoS One (2010) 0.89

The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation. J Virol (2007) 0.88

In transduced cells, the US3 protein kinase of herpes simplex virus 1 precludes activation and induction of apoptosis by transfected procaspase 3. J Virol (2007) 0.88

Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency. J Virol (2004) 0.88

The gene that encodes the herpes simplex virus type 1 latency-associated transcript influences the accumulation of transcripts (Bcl-x(L) and Bcl-x(S)) that encode apoptotic regulatory proteins. J Virol (2003) 0.88

Oncolytic herpes simplex virus interactions with the host immune system. Curr Opin Virol (2016) 0.87

Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells. Apoptosis (2007) 0.87

Evaluation of a continuous quantification method of apoptosis and necrosis in tissue cultures. Cytotechnology (2005) 0.83

Analysis of the genome of leporid herpesvirus 4. Virology (2012) 0.80

Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis. J Cell Death (2013) 0.79

Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes. Vet Res (2013) 0.78

The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J (2016) 0.77

Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells. PLoS One (2015) 0.76

The suppression of apoptosis by α-herpesvirus. Cell Death Dis (2017) 0.75

Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors. Open Virol J (2010) 0.75

Articles by these authors

(truncated to the top 100)

A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22

Entropic elasticity of lambda-phage DNA. Science (1994) 15.40

A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods (1986) 12.51

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26

Large-scale temporal gene expression mapping of central nervous system development. Proc Natl Acad Sci U S A (1998) 9.06

Rapid responses of British butterflies to opposing forces of climate and habitat change. Nature (2001) 8.75

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09

Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52

Mucosal shedding of human herpesvirus 8 in men. N Engl J Med (2000) 6.59

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33

Comparative losses of British butterflies, birds, and plants and the global extinction crisis. Science (2004) 6.18

Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04

The earliest angiosperms: evidence from mitochondrial, plastid and nuclear genomes. Nature (1999) 5.85

Plasma viremia in human immunodeficiency virus infection. N Engl J Med (1989) 5.73

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med (2001) 5.56

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A (1998) 5.48

Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet (1991) 5.42

Chronic fatigue in adolescents. Pediatrics (1991) 5.24

An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat Med (1999) 4.81

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell (1980) 4.62

Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54

Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography. Opt Lett (1997) 4.48

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39

Phase-resolved optical coherence tomography and optical Doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett (2000) 4.33

neurogenin1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia. Neuron (1998) 4.25

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16

DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature (2004) 4.12

Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol (1981) 4.10

Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med (1995) 4.03

Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med (1996) 3.88

Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87

Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med (1994) 3.83

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood (1996) 3.81

A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet (1975) 3.81

The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development (1999) 3.74

The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73

The acquisition of herpes simplex virus during pregnancy. N Engl J Med (1997) 3.73

Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71

A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66

Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60

Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60

Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56

Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56

A number of different nuclear genes for the small subunit of RuBPCase are transcribed in petunia. Nucleic Acids Res (1983) 3.56

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51

Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol (1999) 3.48

Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature (1991) 3.43

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med (1987) 3.42

Modeling plasma virus concentration during primary HIV infection. J Theor Biol (2000) 3.40

Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science (1999) 3.40

The teacher as observer and experimenter in the modification of disputing and talking-out behaviors. J Appl Behav Anal (1971) 3.36

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med (1996) 3.35

Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33

Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem (2001) 3.27

A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature (1997) 3.26

Infections with herpes simplex viruses (1). N Engl J Med (1986) 3.26

Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol (2001) 3.25

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet (2000) 3.22

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med (1980) 3.15

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10

Genetically engineered Saccharomyces yeast capable of effective cofermentation of glucose and xylose. Appl Environ Microbiol (1998) 3.05

The next ten years of health spending: what does the future hold? The Health Expenditures Projection Team. Health Aff (Millwood) (1998) 3.04

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA (1998) 3.03

Stigmatization of AIDS patients by physicians. Am J Public Health (1987) 3.03

Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01

p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res (1993) 2.99

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98

Fluconazole resistant candida in AIDS. J Infect (1991) 2.97

Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood (1999) 2.97

Effect of trends on detrended fluctuation analysis. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 2.95

Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem (1998) 2.93

Evidence for an important role of WRKY DNA binding proteins in the regulation of NPR1 gene expression. Plant Cell (2001) 2.90

Respiratory epithelial cell invasion by group B streptococci. Infect Immun (1992) 2.86

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest (1998) 2.85

A randomised controlled trial of stress reduction for hypertension in older African Americans. Hypertension (1995) 2.85

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med (1995) 2.83

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials. Eur J Clin Pharmacol (2012) 2.80

Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis (2001) 2.79